Innovent Biologics (IVBIY) collaborates with Roche (RHHBY) to develop the antibody-drug conjugate IBI3009 for small cell lung ...

Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

Though lung cancer survival rates are improving, lung cancer is still the leading cause of cancer deaths in the US.

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient ...

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application ...

Edgardo S. Santos, MD, FACP, FASCO, highlighted how liquid biopsies are transforming lung cancer care by enabling faster, ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.